Rhumbline Advisers Tricida, Inc. Transaction History

Rhumbline Advisers

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.14 - $12.49 $231 - $20,633	-1,652 Reduced 3.4%	46,910 $7,000
Q3 2022 Nov 10, 2022	BUY	$8.51 - $13.6 $24,610 - $39,331	2,892 Added 6.33%	48,562 $509,000
Q2 2022 Aug 11, 2022	BUY	$7.31 - $11.85 $333,847 - $541,189	45,670 New	45,670 $442,000
Q2 2021 Aug 05, 2021	SELL	$3.95 - $5.41 $139,158 - $190,594	-35,230 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$4.52 - $7.8 $15,232 - $26,286	-3,370 Reduced 8.73%	35,230 $186,000

Q4 2020 Feb 10, 2021	BUY	$4.37 - $9.46 $15,163 - $32,826	3,470 Added 9.88%	38,600 $272,000
Q3 2020 Nov 12, 2020	SELL	$8.56 - $26.93 $41,858 - $131,687	-4,890 Reduced 12.22%	35,130 $318,000
Q2 2020 Aug 13, 2020	BUY	$21.21 - $31.55 $254,307 - $378,284	11,990 Added 42.78%	40,020 $1.1 Million
Q1 2020 May 06, 2020	BUY	$18.43 - $38.04 $2,598 - $5,363	141 Added 0.51%	28,030 $617,000
Q4 2019 Feb 05, 2020	BUY	$29.6 - $43.71 $17,819 - $26,313	602 Added 2.21%	27,889 $1.05 Million
Q3 2019 Oct 23, 2019	SELL	$29.87 - $42.22 $15,293 - $21,616	-512 Reduced 1.84%	27,287 $842,000
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $154,678 - $195,879	4,964 Added 21.74%	27,799 $1.1 Million
Q1 2019 May 01, 2019	BUY	$19.96 - $38.62 $142,075 - $274,897	7,118 Added 45.29%	22,835 $882,000
Q4 2018 Jan 31, 2019	BUY	$23.57 - $32.33 $161,902 - $222,074	6,869 Added 77.63%	15,717 $371,000
Q3 2018 Nov 07, 2018	BUY	$22.5 - $39.35 $199,080 - $348,168	8,848 New	8,848 $270,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.